Asston Pharmaceuticals Limited logo

Asston Pharmaceuticals Limited (APL)

Market Closed
13 Aug, 22:00
MSE MSE
78. 50
-0.5
-0.6329%
- Market Cap
- P/E Ratio
- Div Yield
2,000 Volume
- Eps
79
Previous Close
Add Transaction
Day Range
78 79
Year Range
60 111.75
Want to track APL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

APL closed today lower at ₹78.5, a decrease of -0.6329% from yesterday's close, completing a monthly increase of 17.1642% or ₹11.5. Over the past 12 months, APL stock lost -4.9637%.
APL is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

APL Chart

Asston Pharmaceuticals Limited (APL) FAQ

What is the stock price today?

The current price is ₹78.50.

On which exchange is it traded?

Asston Pharmaceuticals Limited is listed on MSE.

What is its stock symbol?

The ticker symbol is APL.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Asston Pharmaceuticals Limited ever had a stock split?

No, there has never been a stock split.

Asston Pharmaceuticals Limited Profile

- Industry
- Sector
Ms. Saili Jayaram More CEO
MSE Exchange
- ISIN
India Country
46 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Asston Pharmaceuticals Limited is a dynamic pharmaceutical and nutraceutical manufacturing company established in 2019 and headquartered in Navi Mumbai, India. The company specializes in the development, production, marketing, and export of a wide array of healthcare products. It aims to meet the healthcare needs of diverse markets, focusing significantly on both domestic and international sales, particularly in West African, South African, and Asian regions. Asston Pharmaceuticals prides itself on a robust operational infrastructure, boasting FDA-certified production facilities that adhere to stringent WHO-GMP guidelines, ensuring high-quality and compliance standards for its extensive portfolio of over 150 registered trademarks.

The company actively engages in major therapeutic areas, offering generic medicines, pediatric formulations, anti-tuberculosis treatments, eye drops, and nutritional supplements. With an asset-light operational model, Asston combines in-house manufacturing with strategically placed partnerships for contract production, utilizing WHO-GMP-certified units. This flexibility not only enhances productivity but also strengthens its position in the market, enabling it to cater to direct consumers and corporate clients through effective contract manufacturing and export strategies.

Products and Services

  • Tablets:

    Asston Pharmaceuticals produces a wide variety of tablets, targeting various health concerns and therapeutic areas. These include generic formulations that meet the needs of both domestic and international markets.

  • Capsules:

    The company offers an extensive range of capsule formulations, often containing nutritional supplements and medicines designed to improve patient adherence and therapeutic efficacy.

  • Syrups:

    Asston's syrups are formulated for both pediatric and adult use, ensuring effective delivery of active ingredients for various health conditions, including cough and cold remedies.

  • Sachets:

    The company produces sachets for easy-to-use formulations, particularly in nutritional supplements, allowing for convenient consumption and precise dosing.

  • Ointments, Creams, Gels:

    Asston's topical products include ointments and creams designed for skin care and various medical conditions, as well as gels that offer soothing properties, enhancing patient comfort.

  • Lotions:

    The company develops effective lotions for both therapeutic and cosmetic uses, focusing on skin health and overall well-being.

  • Injectables:

    Asston Pharmaceuticals manufactures a range of injectable formulations that cater to critical therapeutic areas, backed by rigorous quality control and compliance standards.

  • Pediatric Formulations:

    Recognizing the unique healthcare needs of children, Asston offers specialized pediatric formulations, ensuring safety and efficacy in younger populations.

  • Anti-Tuberculosis Treatments:

    The company is involved in manufacturing treatments for tuberculosis, addressing a significant public health challenge in various regions, particularly in emerging markets.

  • Eye Drops:

    Asston Pharmaceuticals produces eye care products, including eye drops formulated for various conditions, ensuring patient comfort and alleviating symptoms effectively.

  • Nutritional Supplements:

    The company's portfolio includes a range of nutritional supplements designed to support overall health, enhance immunity, and improve nutritional intake for various demographics.

Contact Information

Address: Office No A-431 Balaji Bhavan
Phone: 91 22 4973 1419